Total Payments
$31,916
2024 Payments
$1,888
Companies
67
Transactions
1,132
Medicare Patients
7,379
Medicare Billing
$645,750
Payment Breakdown by Category
Food & Beverage$15,525 (48.6%)
Research$15,425 (48.3%)
Travel$921.78 (2.9%)
Education$43.78 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,525 | 1,108 | 48.6% |
| Unspecified | $15,425 | 13 | 48.3% |
| Travel and Lodging | $921.78 | 3 | 2.9% |
| Education | $43.78 | 8 | 0.1% |
Payments by Type
General
$16,491
1,119 transactions
Research
$15,425
13 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $14,534 | 42 | $0 (2023) |
| GlaxoSmithKline, LLC. | $2,017 | 176 | $0 (2024) |
| Novo Nordisk Inc | $1,451 | 95 | $0 (2024) |
| SANOFI US SERVICES INC. | $1,442 | 9 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $1,439 | 95 | $0 (2024) |
| Novo Nordisk AS | $1,197 | 4 | $0 (2017) |
| ABBVIE INC. | $911.81 | 73 | $0 (2024) |
| Merck Sharp & Dohme LLC | $782.80 | 72 | $0 (2024) |
| Dexcom, Inc. | $703.32 | 64 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $632.46 | 50 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,888 | 123 | AstraZeneca Pharmaceuticals LP ($300.98) |
| 2023 | $2,067 | 139 | GlaxoSmithKline, LLC. ($317.39) |
| 2022 | $1,603 | 114 | Dexcom, Inc. ($199.12) |
| 2021 | $1,583 | 100 | GlaxoSmithKline, LLC. ($307.76) |
| 2020 | $1,327 | 99 | GlaxoSmithKline, LLC. ($218.65) |
| 2019 | $16,123 | 173 | SANOFI-AVENTIS U.S. LLC ($14,121) |
| 2018 | $3,379 | 165 | SANOFI US SERVICES INC. ($1,442) |
| 2017 | $3,947 | 219 | Novo Nordisk AS ($1,197) |
All Payment Transactions
1,132 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Automated insulin delivery system | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $8.40 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: ANTIBIOTIC | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: GI | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.02 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Biological | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $20.69 | General |
| Category: Medical Device | ||||||
| 10/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $2.08 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A 26-week randomized, open-label, active-controlled, 2-treatment arm, parallel group multi-center study, comparing the efficacy and safety of Soliqua 100/33 versus Lantus in ethnically/racially divers | SANOFI-AVENTIS U.S. LLC | $9,652 | 2 |
| A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers | SANOFI-AVENTIS U.S. LLC | $4,331 | 2 |
| A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua?100/33 Versus Lantus? in Ethnically/Racially Di | SANOFI US SERVICES INC. | $1,442 | 9 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,442 | 5,204 | $430,481 | $132,955 |
| 2022 | 36 | 1,712 | 5,005 | $485,241 | $160,150 |
| 2021 | 41 | 2,096 | 3,117 | $501,043 | $169,173 |
| 2020 | 46 | 2,129 | 6,153 | $515,762 | $183,471 |
Total Patients
7,379
Total Services
19,479
Medicare Billing
$645,750
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 377 | $69,745 | $28,857 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 441 | $72,765 | $25,889 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 140 | 140 | $32,900 | $16,692 | 50.7% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2023 | 17 | 2,875 | $74,031 | $15,253 | 20.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 17 | 84 | $15,540 | $6,824 | 43.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 46 | 47 | $21,150 | $6,005 | 28.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 18 | 123 | $17,505 | $5,708 | 32.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 177 | 208 | $28,080 | $4,275 | 15.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 22 | $6,050 | $3,294 | 54.5% |
| 27369 | Injection of contrast for imaging of knee joint | Office | 2023 | 14 | 21 | $5,775 | $2,773 | 48.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 60 | $7,500 | $2,160 | 28.8% |
| 73580 | Review by radiologist of knee joint image | Office | 2023 | 15 | 22 | $5,280 | $2,007 | 38.0% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 26 | 60 | $9,600 | $1,816 | 18.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 163 | 179 | $13,425 | $1,553 | 11.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,560 | $1,364 | 29.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 38 | 38 | $5,700 | $1,291 | 22.6% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 17 | 17 | $3,655 | $1,018 | 27.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,815 | $940.50 | 51.8% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 11 | 11 | $2,420 | $758.97 | 31.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 33 | 33 | $4,785 | $721.89 | 15.1% |
| 70220 | X-ray of paranasal sinus, minimum of 3 views | Office | 2023 | 23 | 29 | $3,335 | $716.00 | 21.5% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 18 | 18 | $3,420 | $694.80 | 20.3% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 27 | 28 | $4,900 | $662.63 | 13.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 11 | 11 | $2,475 | $489.25 | 19.8% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 20 | 21 | $3,885 | $431.90 | 11.1% |
About Dr. Leon Davis, MD
Dr. Leon Davis, MD is a Internal Medicine healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265493134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leon Davis, MD has received a total of $31,916 in payments from pharmaceutical and medical device companies, with $1,888 received in 2024. These payments were reported across 1,132 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($15,525).
As a Medicare-enrolled provider, Davis has provided services to 7,379 Medicare beneficiaries, totaling 19,479 services with total Medicare billing of $645,750. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Montgomery, AL
- Active Since 03/30/2006
- Last Updated 04/16/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265493134
Products in Payments
- SOLIQUA 100/33 (Drug) $9,698
- ADLYXIN (Drug) $4,331
- SOLIQUA (Drug) $1,537
- Tresiba (Drug) $1,398
- TRELEGY ELLIPTA (Drug) $1,339
- Dexcom G6 Transmitter (Medical Supply) $677.35
- FARXIGA (Drug) $669.17
- Ozempic (Drug) $619.33
- JANUVIA (Drug) $528.45
- VRAYLAR (Drug) $448.66
- Victoza (Drug) $429.13
- ANORO (Drug) $367.75
- XARELTO (Drug) $360.60
- SYMBICORT (Drug) $334.96
- UBRELVY (Drug) $319.84
- Vascepa (Drug) $300.36
- JARDIANCE (Drug) $294.46
- Kerendia (Drug) $287.72
- INVOKANA (Drug) $265.84
- FREESTYLE LIBRE 2 (Device) $238.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Montgomery
Dr. April Truett, M.d, M.D
Internal Medicine — Payments: $83,466
Internal Medicine $83,466
Dr. John Jernigan, M.d, M.D
Internal Medicine — Payments: $52,323
Internal Medicine $52,323
Dr. Joel Mccloud, M.d, M.D
Internal Medicine — Payments: $48,226
Internal Medicine $48,226
Dr. Muhammad Athar, M.d, M.D
Internal Medicine — Payments: $31,442
Internal Medicine $31,442
John Eckman, M.d, M.D
Internal Medicine — Payments: $28,791
Internal Medicine $28,791
Dr. Norman Taylor, M.d, M.D
Internal Medicine — Payments: $22,168
Internal Medicine $22,168